Jean-François Tanguay

Jean-François Tanguay

Auto-generated profile, based on publicly available information

Jean-François Tanguay

Research Center, Montreal Heart Institute, 5000 Bélanger Street, Montreal, QC, H1T 1C8, Canada.

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
SMShamir R. Mehta
Shamir R. Mehta
KBKevin R. Bainey
Kevin R. Bainey
WCWarren J. Cantor
Warren J. Cantor
MLMarie Lordkipanidze
Marie Lordkipanidze
GMGuillaume Marquis-Gravel
Guillaume Marquis-Gravel
RWRobert Welsh
Robert Welsh

1 November 2013 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
JTJean-François Tanguay
Jean-François Tanguay
ABAlan D. Bell
Alan D. Bell
MAMargaret L. Ackman
Margaret L. Ackman
RBRobert D.C. Bauer
Robert D.C. Bauer
RCRaymond Cartier
Raymond Cartier
SMShamir R. Mehta
Shamir R. Mehta

14 December 2011 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
SASouhad El Akoum
Souhad El Akoum
VLVikie Lamontagne
Vikie Lamontagne
ICIsabelle Cloutier
Isabelle Cloutier
JTJean-François Tanguay
Jean-François Tanguay
Background: Adverse effects of high-fat diets (HFD) on metabolic homeostasis are linked to adipose tissue dysfunction. The goal of this study was to examine the effect of the HFD nature on adipose tissue activity, metabolic disturbances and glucose homeostasis alterations in male mice compared with female mice. Methods: C57BL/6J mice were fed either a chow diet or HFD including vegetal (VD) or animal (AD) fat. Body weight, plasmatic parameters and adipose tissue mRNA expression levels of key genes were evaluated after 20 weeks of HFD feeding. Results: HFD-fed mice were significantly heavier than control at the end of the protocol. Greater abdominal visceral fat accumulation was observed in mice fed with AD compared to those fed a chow diet or VD. Correlated with weight gain, leptin levels in systemic circulation were increased in HFD-fed mice in both sexes with a significant higher level in AD group compared to VD group. Circulating adiponectin levels as well as adipose tissue mRNA expression levels were significantly decreased in HFD-fed male mice. Although its plasma levels remained unchanged in females, adiponectin mRNA levels were significantly reduced in adipose tissue of both HFD-fed groups with a more marked decrease in AD group compared to VD group. Only HFD-fed male mice were diabetic with increased fasting glycaemia. On the other hand, insulin levels were only increased in AD-fed group in both sexes associated with increased resistin levels. VD did not induce any apparent metabolic alteration in females despite the increased weight gain. Peroxisome Proliferator-Activated Receptors gamma-2 (PPARγ2) and estrogen receptor alpha (ERα) mRNA expression levels in adipose tissue were decreased up to 70% in HFD-fed mice but were more markedly reduced in male mice as compared with female mice. Conclusions: The nature of dietary fat determines the extent of metabolic alterations reflected in adipocytes through modifications in the pattern of adipokines secretion and modulation of key genes mRNA expression. Compared with males, female mice demonstrate higher capacity in controlling glucose homeostasis in response to 20 weeks HFD feeding. Our data suggest gender specific interactions between the diet's fatty acid source, the adipocyte-secreted proteins and metabolic disorders.

18 August 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
GFGuillaume Fontaine
Guillaume Fontaine
SCSylvie Cossette
Sylvie Cossette
SHSonia Heppell
Sonia Heppell
LBLouise Boyer
Louise Boyer
TMTanya Mailhot
Tanya Mailhot
JTJean-Francois Tanguay
Jean-Francois Tanguay
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 January 2004 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
JTJean-François Tanguay
Jean-François Tanguay
PGPascale Geoffroy
Pascale Geoffroy
MSMartin Sirois
Martin Sirois
DLDanielle Libersan
Danielle Libersan
AKAnjali Kumar
Anjali Kumar
YMYahye Merhi
Yahye Merhi
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren Zeitschriftenartikeln

31 October 2012 in Molecular and Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
ÉCÉmilie Cossette
Émilie Cossette
ICIsabelle Cloutier
Isabelle Cloutier
KTKim Tardif
Kim Tardif
GDGeneviève DonPierre
Geneviève DonPierre
JTJean-François Tanguay
Jean-François Tanguay
In addition of being an important inflammatory biomarker and a risk factor for cardiovascular disease, much evidence indicates that the C-reactive protein (CRP) contributes to the atherosclerosis development process. This plasmatic protein synthesized by hepatocytes in response to inflammation and tissue injury induces pro-inflammatory molecules' expression by endothelial cells (ECs). Previous studies showed that the 17β-estradiol (E2) has beneficial effects on vascular cells by reducing in vitro pro-inflammatory molecules expressions in EC. Therefore, we hypothesize that E2 blocks or reduces CRP-mediated inflammatory responses by modulating endogenous production of CRP in EC and/or activation mechanisms. Using human aortic ECs (HAECs), we first evaluated CRP production by vascular EC and second demonstrated its self-induction. Indeed, recombinant human CRP stimulation induces a fivefold increase of CRP expression. A 1-h pre-treatment of E2 at a physiologic dose (10−9 M) leads to an important decrease of CRP production suggesting a partial blockage of its amplification loop mechanism. Furthermore, in HAEC, E2 reduces the secretion of the most potent agonist of CRP induction, the IL-6, by 21 %. E2 pre-treatment also decreased the expression of pro-inflammatory molecules IL-8, VCAM-1, and ICAM-1 induced by CRP and involved in leukocytes recruitment. In addition, we demonstrated that E2 could restore vascular endothelial growth factor-mediated EC migration response impaired by CRP suggesting another pro-angiogenic property of this hormone. These findings suggest that E2 can interfere with CRP pro-inflammatory effects via activation signals using its rapid, non-genomic pathway that may provide a new mechanism to improve vascular repair.